Home Healthcare IT Glioblastoma Multiforme (GBM) Treatment Market Size, Share and Forecast by 2033

Glioblastoma Multiforme (GBM) Treatment Market Size & Outlook, 2025-2033

Glioblastoma Multiforme (GBM) Treatment Market Size, Share & Trends Analysis Report By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy), By Drugs (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI54835DR
Last Updated : Jun, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. Glioblastoma Multiforme (GBM) Treatment Market, By Treatment (2021-2033)
    1. Surgery
    2. Radiation Therapy
    3. Chemotherapy
    4. Targeted Therapy
    5. Tumor Treating Field (TTF) Therapy
    6. Immunotherapy
  2. Glioblastoma Multiforme (GBM) Treatment Market, By Drugs (2021-2033)
    1. Temozolomide
    2. Bevacizumab
    3. Lomustine
    4. Carmustine Wafers
    5. Others
  3. Glioblastoma Multiforme (GBM) Treatment Market, By End-User (2021-2033)
    1. Hospitals
    2. Clinics
    3. Ambulatory Surgical Centers
    1. North America
      1. North America Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
        1. Surgery
          1. Radiation Therapy
            1. Chemotherapy
              1. Targeted Therapy
                1. Tumor Treating Field (TTF) Therapy
                  1. Immunotherapy
                  2. North America Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                    1. Temozolomide
                      1. Bevacizumab
                        1. Lomustine
                          1. Carmustine Wafers
                            1. Others
                            2. North America Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                              1. Hospitals
                                1. Clinics
                                  1. Ambulatory Surgical Centers
                                  2. U.S.
                                    1. U.S. Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                      1. Surgery
                                        1. Radiation Therapy
                                          1. Chemotherapy
                                            1. Targeted Therapy
                                              1. Tumor Treating Field (TTF) Therapy
                                                1. Immunotherapy
                                                2. U.S. Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                  1. Temozolomide
                                                    1. Bevacizumab
                                                      1. Lomustine
                                                        1. Carmustine Wafers
                                                          1. Others
                                                          2. U.S. Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                            1. Hospitals
                                                              1. Clinics
                                                                1. Ambulatory Surgical Centers
                                                              2. Canada
                                                            2. Europe
                                                              1. Europe Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                1. Surgery
                                                                  1. Radiation Therapy
                                                                    1. Chemotherapy
                                                                      1. Targeted Therapy
                                                                        1. Tumor Treating Field (TTF) Therapy
                                                                          1. Immunotherapy
                                                                          2. Europe Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                            1. Temozolomide
                                                                              1. Bevacizumab
                                                                                1. Lomustine
                                                                                  1. Carmustine Wafers
                                                                                    1. Others
                                                                                    2. Europe Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                      1. Hospitals
                                                                                        1. Clinics
                                                                                          1. Ambulatory Surgical Centers
                                                                                          2. U.K.
                                                                                            1. U.K. Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                              1. Surgery
                                                                                                1. Radiation Therapy
                                                                                                  1. Chemotherapy
                                                                                                    1. Targeted Therapy
                                                                                                      1. Tumor Treating Field (TTF) Therapy
                                                                                                        1. Immunotherapy
                                                                                                        2. U.K. Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                          1. Temozolomide
                                                                                                            1. Bevacizumab
                                                                                                              1. Lomustine
                                                                                                                1. Carmustine Wafers
                                                                                                                  1. Others
                                                                                                                  2. U.K. Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                    1. Hospitals
                                                                                                                      1. Clinics
                                                                                                                        1. Ambulatory Surgical Centers
                                                                                                                      2. Germany
                                                                                                                      3. France
                                                                                                                      4. Spain
                                                                                                                      5. Italy
                                                                                                                      6. Russia
                                                                                                                      7. Nordic
                                                                                                                      8. Benelux
                                                                                                                      9. Rest of Europe
                                                                                                                    2. APAC
                                                                                                                      1. APAC Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                        1. Surgery
                                                                                                                          1. Radiation Therapy
                                                                                                                            1. Chemotherapy
                                                                                                                              1. Targeted Therapy
                                                                                                                                1. Tumor Treating Field (TTF) Therapy
                                                                                                                                  1. Immunotherapy
                                                                                                                                  2. APAC Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                    1. Temozolomide
                                                                                                                                      1. Bevacizumab
                                                                                                                                        1. Lomustine
                                                                                                                                          1. Carmustine Wafers
                                                                                                                                            1. Others
                                                                                                                                            2. APAC Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                              1. Hospitals
                                                                                                                                                1. Clinics
                                                                                                                                                  1. Ambulatory Surgical Centers
                                                                                                                                                  2. China
                                                                                                                                                    1. China Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                      1. Surgery
                                                                                                                                                        1. Radiation Therapy
                                                                                                                                                          1. Chemotherapy
                                                                                                                                                            1. Targeted Therapy
                                                                                                                                                              1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                1. Immunotherapy
                                                                                                                                                                2. China Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                  1. Temozolomide
                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                      1. Lomustine
                                                                                                                                                                        1. Carmustine Wafers
                                                                                                                                                                          1. Others
                                                                                                                                                                          2. China Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                            1. Hospitals
                                                                                                                                                                              1. Clinics
                                                                                                                                                                                1. Ambulatory Surgical Centers
                                                                                                                                                                              2. Korea
                                                                                                                                                                              3. Japan
                                                                                                                                                                              4. India
                                                                                                                                                                              5. Australia
                                                                                                                                                                              6. Taiwan
                                                                                                                                                                              7. South East Asia
                                                                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                              1. Middle East and Africa Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                1. Surgery
                                                                                                                                                                                  1. Radiation Therapy
                                                                                                                                                                                    1. Chemotherapy
                                                                                                                                                                                      1. Targeted Therapy
                                                                                                                                                                                        1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                          1. Immunotherapy
                                                                                                                                                                                          2. Middle East and Africa Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                            1. Temozolomide
                                                                                                                                                                                              1. Bevacizumab
                                                                                                                                                                                                1. Lomustine
                                                                                                                                                                                                  1. Carmustine Wafers
                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                    2. Middle East and Africa Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                      1. Hospitals
                                                                                                                                                                                                        1. Clinics
                                                                                                                                                                                                          1. Ambulatory Surgical Centers
                                                                                                                                                                                                          2. UAE
                                                                                                                                                                                                            1. UAE Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                                              1. Surgery
                                                                                                                                                                                                                1. Radiation Therapy
                                                                                                                                                                                                                  1. Chemotherapy
                                                                                                                                                                                                                    1. Targeted Therapy
                                                                                                                                                                                                                      1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                                                        1. Immunotherapy
                                                                                                                                                                                                                        2. UAE Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                                                          1. Temozolomide
                                                                                                                                                                                                                            1. Bevacizumab
                                                                                                                                                                                                                              1. Lomustine
                                                                                                                                                                                                                                1. Carmustine Wafers
                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                  2. UAE Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                                                      1. Clinics
                                                                                                                                                                                                                                        1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                      1. LATAM Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                                                                        1. Surgery
                                                                                                                                                                                                                                          1. Radiation Therapy
                                                                                                                                                                                                                                            1. Chemotherapy
                                                                                                                                                                                                                                              1. Targeted Therapy
                                                                                                                                                                                                                                                1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                                                                                  1. Immunotherapy
                                                                                                                                                                                                                                                  2. LATAM Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                                                                                    1. Temozolomide
                                                                                                                                                                                                                                                      1. Bevacizumab
                                                                                                                                                                                                                                                        1. Lomustine
                                                                                                                                                                                                                                                          1. Carmustine Wafers
                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                            2. LATAM Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                                                                              1. Hospitals
                                                                                                                                                                                                                                                                1. Clinics
                                                                                                                                                                                                                                                                  1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                                                  2. Brazil
                                                                                                                                                                                                                                                                    1. Brazil Glioblastoma Multiforme (GBM) Treatment Market, By Treatment
                                                                                                                                                                                                                                                                      1. Surgery
                                                                                                                                                                                                                                                                        1. Radiation Therapy
                                                                                                                                                                                                                                                                          1. Chemotherapy
                                                                                                                                                                                                                                                                            1. Targeted Therapy
                                                                                                                                                                                                                                                                              1. Tumor Treating Field (TTF) Therapy
                                                                                                                                                                                                                                                                                1. Immunotherapy
                                                                                                                                                                                                                                                                                2. Brazil Glioblastoma Multiforme (GBM) Treatment Market, By Drugs
                                                                                                                                                                                                                                                                                  1. Temozolomide
                                                                                                                                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                                                                                                                                      1. Lomustine
                                                                                                                                                                                                                                                                                        1. Carmustine Wafers
                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                          2. Brazil Glioblastoma Multiforme (GBM) Treatment Market, By End-User
                                                                                                                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                                                                                                                              1. Clinics
                                                                                                                                                                                                                                                                                                1. Ambulatory Surgical Centers
                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                          Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                          Get This Report

                                                                                                                                                                                                                                                                                          Download Free Sample

                                                                                                                                                                                                                                                                                          Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                          The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                          Our Clients:

                                                                                                                                                                                                                                                                                          LG Electronics
                                                                                                                                                                                                                                                                                          AMCAD Engineering
                                                                                                                                                                                                                                                                                          KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                          Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                          Voith Group
                                                                                                                                                                                                                                                                                          International Paper
                                                                                                                                                                                                                                                                                          Hansol Paper
                                                                                                                                                                                                                                                                                          Whirlpool Corporation
                                                                                                                                                                                                                                                                                          Sony
                                                                                                                                                                                                                                                                                          Samsung Electronics
                                                                                                                                                                                                                                                                                          Qualcomm
                                                                                                                                                                                                                                                                                          Google
                                                                                                                                                                                                                                                                                          Fiserv
                                                                                                                                                                                                                                                                                          Veto-Pharma
                                                                                                                                                                                                                                                                                          Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                          Merck
                                                                                                                                                                                                                                                                                          Argon Medical Devices
                                                                                                                                                                                                                                                                                          Abbott
                                                                                                                                                                                                                                                                                          Ajinomoto
                                                                                                                                                                                                                                                                                          Denon
                                                                                                                                                                                                                                                                                          Doosan
                                                                                                                                                                                                                                                                                          Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                          LG Chemicals
                                                                                                                                                                                                                                                                                          LCY chemical group
                                                                                                                                                                                                                                                                                          Bayer
                                                                                                                                                                                                                                                                                          Airrane
                                                                                                                                                                                                                                                                                          BASF
                                                                                                                                                                                                                                                                                          Toyota Industries
                                                                                                                                                                                                                                                                                          Nissan Motors
                                                                                                                                                                                                                                                                                          Neenah
                                                                                                                                                                                                                                                                                          Mitsubishi
                                                                                                                                                                                                                                                                                          Hyundai Motor Company

                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                          Address:
                                                                                                                                                                                                                                                                                          Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                          Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                          Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                          Contact Us:
                                                                                                                                                                                                                                                                                          +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                          +91 8087085354 (India)
                                                                                                                                                                                                                                                                                          +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                          sales@straitsresearch.com

                                                                                                                                                                                                                                                                                          Quick Links
                                                                                                                                                                                                                                                                                          Help
                                                                                                                                                                                                                                                                                          Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                          DMCA.com Protection Status
                                                                                                                                                                                                                                                                                          Secure Payments:
                                                                                                                                                                                                                                                                                          Follow Us:
                                                                                                                                                                                                                                                                                          www.straitsresearch.com © Copyright . All rights Reserved.